Salinas-Torres VM, Aguirre-Jáuregui OM, Pérez-García G, Cadena-González PJ, Raya-Trigueros A, Gutiérrez-Padilla JA

Language: Spanish
References: 27
Page: 50-55
PDF size: 310.93 Kb.

ABSTRACT

Background. The epidemiological and demographic transition in Mexico demonstrates the frequency of health-related conditions related to illegal drug use in women of childbearing age. Maternal abuse of cocaine during pregnancy is associated with teratogenic effects in the embryo affecting chiefly brain, heart, urogenital tract and extremities, with serious consequences affecting function and/or quality of life of the newborns.
Case report. We present the case of a 3-day-old male who presented transverse meromelia in all four limbs with characteristic facie. Parents reported consumption of cocaine. The mother reported consuming cocaine prior to and during the first trimester of pregnancy and self-report was verified along with toxicological urine testing.
Conclusions. Studies associated with consumption of teratogenic agents are important to carry out in order to expand scientific knowledge and to establish measures of prevention and treatment of these pathologies.

REFERENCES

1. Brown E, Prager J, Lee HY, Ramsey RG. CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. AJR 1992;159:137-147.

2. Bauer CR, Langer JC, Shankaran S, Bada HS, Lester B, Wright LL, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 2005;159:824-834.

3. Meyer KD, Zhang L. Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development. Ther Adv Cardiovasc Dis 2009;3:7-16.

4. Chiriboga CA, Kuhn L, Wasserman GA. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior. Neurotoxicol Teratol 2007;29:323-330.

5. Bhide PG. Dopamine, cocaine and the development of cerebral cortical cytoarchitecture: a review of current concepts. Semin Cell Dev Biol 2009;20:395-402.

6. Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK, et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 1990;85:743-747.

7. Rieder MJ. How much fire under the smoke? The effects of exposure to cocaine on the fetus. CMAJ 1994;151:1567-1569.

8. Gorlin RJ, Cohen MM Jr, Hennekam RCM. Cocaine embryopathy. En: Gorlin RJ, Cohen MM Jr, Hennekam RCM, eds. Syndromes of the Head and Neck. USA: Oxford University Press; 2001. pp. 17-18.

9. Addis A, Moretti ME, Syed FA, Einarson TR, Koren G. Fetal effects of cocaine: an update meta-analysis. Reprod Toxicol 2001;15:341-369.

10. Kashiwagi M, Chaoui R, Stallmach T, Hürlimann S, Lauper U, Hebisch G. Fetal bilateral renal agenesis, phocomelia, and single umbilical artery associated with cocaine abuse in early pregnancy. Birth Defects Research A Clin Mol Teratol 2003;67:951-952.

11. Malanga CJ, Pejchal M, Kosofsky BE. Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice. Pharmacol Biochem Behav 2007;87:462-471.

12. Richardson GA, Goldschmidt L, Willford J. The effects of prenatal cocaine use on infant development. Neurotoxicol Teratol 2008;30:96-106.

13. Hurt H, Brodsky NL, Roth H, Malmud E, Giannetta JM. School performance of children with gestational cocaine exposure. Neurotoxicol Teratol 2005;27:203-211.

14. Richardson GA, Goldschmidt L, Willford J. Continued effects of prenatal cocaine use: preschool development. Neurotoxicol Teratol 2009;31:325-333.

15. Kuhn L, Kline J, Ng S, Levin B, Susser M. Cocaine use during pregnancy and intrauterine grow retardation: new insights based on maternal hair tests. Am J Epidemiol 2000;152:112-119.

16. Encuesta Nacional de Adicciones 2008. Instituto Nacional de Salud Pública, México. Disponible en: http://www.insp.mx/images/stories/Produccion/pdf/100722_cp8.pdf

17. Gutiérrez-Padilla JA, González-Garrido AA, Gómez-Velázquez FR, de la Torre-Gutiérrez M, Ávalos-Huizar LM, García- Hernández H, et al. Hijos de madres adictas con síndrome de abstinencia en Terapia Intensiva Neonatal. Bol Med Hosp Infant Mex 2008;65:276-281.

18. NOM-028-SSA2-1999, para la prevención, tratamiento y control de las adicciones. Secretaria de Salud, México. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/028ssa29.html

19. Stevenson RE. Limbs. En: Stevenson RE, Hall JG, eds. Human Malformations and Related Anomalies. USA: Oxford University Press; 2006. pp. 835-856.

20. Ghanem I. Epidemiology, etiology, and genetic aspects of reduction deficiencies of the lower limb. J Child Orthop 2008;2:329-332.

21. Rogala EJ, Wynne-Davies R, Littlejohn A, Gormley J. Congenital limb anomalies: frequency and etiological factors. Data from the Edinburg Register of the Newborn (1964-68). J Med Genet 1974;11:221-233.

22. Weaver DD. Vascular etiology of limb defects: the subclavian artery supply disruption sequence. En: Herring JA, Birch JG, eds. The Child with a Limb Deficiency. Rosemont: Amer Academy of Orthopaedic; 1998. pp. 25-32.

23. Otsuji M, Takahara M, Naruse T, Guan D, Harada M, Zhe P, et al. Developmental abnormalities in rat embryos leading to tibial ray deficiencies inducen by busulfan. Birth Defects Res A Clin Mol Teratol 2005;73:461-467.

24. Schardein JL. Personal and social drugs. En: Schardein JL, editor. Chemically Induced Birth Defects. New York/Basel: Marcel Dekker Inc; 2000. p. 733.

25. Castriota-Scanderbeg A, Dallapiccola B. Roberts Syndrome. En: Castriota-Scanderbeg A, Dallapiccola B, eds. Abnormal Skeletal Phenotypes. From Simple Signs to Complex Diagnoses. Berlin: Springer-Verlag; 2005. pp. 849-850.

26. Comité de Apoyo Integral al Menor Maltratado. Disponible en: http://caimm-hcg.blogspot.com/

27. Centro de Estudios de Alcoholismo y Adicciones. Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud. Disponible en: http://www.cucs.udg.mx/alcoholismo/